Home / 2011 (page 5)

Yearly Archives: 2011

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

The regulation of food intake is a complex process involving psychologic, social, and physiologic components. Physiologically, it is generally assumed that food intake is regulated by a central feeding drive that is later counterregulated by peripheral satiety signals that are activated during a meal. These satiety signals have been suggested …

Read More »

“On-Track Diabetes” App for Patients

OnTrack

  This app lets you log values such as glucose readings, food, exercise, and medications. Each event is entered by selecting a type (e.g., exercise), and a subtype (e.g., “swimming”) from an easily customized subtype menu. This saves time because you don’t have to type in the subtype each time. …

Read More »

Editor’s Note: New Homerun Slides on CVD

Over the past weeks we have shared some great slides on Advanced Glycation End-products, and there’s a lot linking these AGE’s to cardiovascular disease. Our publisher, Steve Freed, has been working with Stan Schwartz, MD, FACP, Clinical Associate Professor of Medicine, University of Pennsylvania, and this week we have a whole …

Read More »

How Old Are You Really?

Sheri

By Sheri Colberg, PhD Different tissues and organs change over time at varying rates, so enhancing their function will likely slow your rate of biological aging and, in some cases, even reverse it. Certain biomarkers of biological aging can let you know whether you’re doing better or worse than your …

Read More »

SPECIAL FEATURE: GLP-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects

alt

Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO PART 2: GLP 1 Agonist-based Therapies: How do they reduce cardiovascular risks in diabetic patients? (For Part 1, just click here.) GLP-1 Agonist-based Therapies Reduce Cardiovascular Risk Weight loss is critical …

Read More »

FDA Restricts Lap-Band Claims

FDA Restricts Lap-Band Claims “I lost 90 pounds with the Lap-Band” should also include that it has Serious Risks. FDA has warned eight surgical centers and a marketing firm in California about misleading advertising of the Lap-Band.

Read More »

Duo AutoShield™

Autoshield

Duo AutoShield™ Duo is a next generation, 5mm safety-engineered pen needle designed to protect healthcare workers from needlestick injuries and blood exposure. It is now available in the US from BD Medical. The AutoShield™ Duo is the only pen needle with front and back-end needle protection. The safety mechanisms activate …

Read More »